LIVERSIDGE; Elaine
Patent Applications and Registrations
Patent applications and USPTO patent grants for LIVERSIDGE; Elaine.The latest application filed is for "aripiprazole prodrug composition".
- LIVERSIDGE; Elaine - Charlestown MA
- Liversidge; Elaine - West Chester PA
- Liversidge; Elaine - Westchester PA
| Patent | Date |
|---|---|
| Aripiprazole Prodrug Composition App 20220079939 - CRESSWELL; Philip ; et al. | 2022-03-17 |
| Aripiprazole prodrug composition Grant 11,154,552 - Cresswell , et al. October 26, 2 | 2021-10-26 |
| Aripiprazole prodrug composition Grant 10,849,894 - Cresswell , et al. December 1, 2 | 2020-12-01 |
| Aripiprazole Prodrug Composition App 20200316061 - CRESSWELL; Philip ; et al. | 2020-10-08 |
| Aripiprazole prodrug composition Grant 10,688,091 - Cresswell , et al. | 2020-06-23 |
| Aripiprazole Prodrug Composition App 20190269676 - CRESSWELL; Philip ; et al. | 2019-09-05 |
| Aripiprazole Prodrug Composition App 20180318293 - Cresswell; Philip ; et al. | 2018-11-08 |
| Aripiprazole prodrug compositions Grant 10,016,415 - Cresswell , et al. July 10, 2 | 2018-07-10 |
| Aripiprazole Prodrug Compositions App 20160045495 - CRESSWELL; Philip ; et al. | 2016-02-18 |
| Pharmaceutical composition of a tachykinin receptor antagonist Grant 8,258,132 - Bosch , et al. September 4, 2 | 2012-09-04 |
| Stabilization Of Chemical Compounds Using Nanoparticulate Formulations App 20120087984 - LIVERSIDGE; Elaine ; et al. | 2012-04-12 |
| Nanoparticulate statin formulations and novel statin combinations App 20110027371 - Cooper; Eugene R. ; et al. | 2011-02-03 |
| Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions Grant RE41,884 - de Garavilla , et al. October 26, 2 | 2010-10-26 |
| Nanoparticulate Tacrolimus Formulations App 20090252806 - JENKINS; Scott ; et al. | 2009-10-08 |
| Nanoparticulate Compositions Of Immunosuppressive Agents App 20090175951 - LIVERSIDGE; Elaine ; et al. | 2009-07-09 |
| Nanoparticle dispersion containing lactam compound App 20090004277 - Franchini; Miriam K. ; et al. | 2009-01-01 |
| Nanoparticulate statin formulations and novel statin combinations App 20080213378 - Cooper; Eugene R. ; et al. | 2008-09-04 |
| Nanoparticulate tacrolimus formulations App 20080152720 - Jenkins; Scott ; et al. | 2008-06-26 |
| Stabilization of chemical compounds using nanoparticulate formulations App 20070224279 - Liversidge; Elaine ; et al. | 2007-09-27 |
| Nanoparticulate insulin App 20070122486 - McGurk; Simon ; et al. | 2007-05-31 |
| Nanoparticulate formulations of docetaxel and analogues thereof App 20060188566 - Liversidge; Gary ; et al. | 2006-08-24 |
| Nanoparticulate tacrolimus formulations App 20060159766 - Jenkins; Scott ; et al. | 2006-07-20 |
| Compositions comprising antibodies and methods of using the same for targeting nanoparticulate active agent delivery App 20050147664 - Liversidge, Elaine ; et al. | 2005-07-07 |
| Pharmaceutical composition of a tachykinin receptor antagonist App 20040214746 - Bosch, H. William ; et al. | 2004-10-28 |
| Milling microgram quantities of nanoparticulate candidate compounds App 20040173696 - Cunningham, James ; et al. | 2004-09-09 |
| Nanoparticulate nystatin formulations App 20040018242 - Cunningham, James ; et al. | 2004-01-29 |
| Nanoparticulate insulin App 20030095928 - McGurk, Simon ; et al. | 2003-05-22 |
| Stabilization of chemical compounds using nanoparticulate formulations App 20030054042 - Liversidge, Elaine ; et al. | 2003-03-20 |
| Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions Grant 6,270,806 - Liversidge , et al. August 7, 2 | 2001-08-07 |
| Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions Grant 6,267,989 - Liversidge , et al. July 31, 2 | 2001-07-31 |
| Surface modified anticancer nanoparticles Grant 5,494,683 - Liversidge , et al. February 27, 1 | 1996-02-27 |
| Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents Grant 5,401,492 - Kellar , et al. March 28, 1 | 1995-03-28 |
| Surface modified anticancer nanoparticles Grant 5,399,363 - Liversidge , et al. March 21, 1 | 1995-03-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 